专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2016007767A3 ASSIGNMENT OF QUALITATIVE IMPORTANCE OF GENETIC PHENOTYPES TO THE USE OF DRUGS BASED ON GENETIC TEST RESULTS 审中-公开
标题翻译：遗传性表型对基于遗传检验结果的药物使用的定性重要性的分配
公开(公告)号：WO2016007767A3
公开(公告)日：2016-01-14
申请号：PCT/US2015/039778
申请日：2015-07-09
申请人： ELEVATED CAPITAL GROUP LLC
发明人： MASSEY, Bill, W. , ZIMMER, Richard , MONEY, Jason , ST. PIERRE, Christopher
IPC分类号： C12Q1/68 , G06F19/18 , G06F19/12
摘要： The present invention is a method for assigning a qualitative importance of relevant genetic phenotypes to the use of specific drugs for individual patients based on genetic test results. The invention provides a drug-centric integration of pharmacogenetic test information across multiple genes relevant to an individual drug. The invention then assigns a color designation for each drug reported and groups the drugs together on a report according to drug class/therapeutic area, thus allowing the physician to easily and quickly identify a drug from a specific drug class that would be best for that patient according to their entire pharmacogenetic test results. The outputs of the method can be added to existing pharmacogenetic test reports as a quick guide for the physician. Such integration of pharmacogenetic information from multiple genes and drug-centric organization of the outputs should allow physicians to more easily utilize and incorporate pharmacogenetic testing into their practice.
摘要翻译：本发明是一种基于遗传测试结果将相关遗传表型的定性重要性分配给个体患者使用特定药物的方法。本发明提供跨多个与单独药物相关的基因的药物遗传学测试信息的以药物为中心的整合。然后，本发明为报告的每种药物指定一种颜色名称，并根据药物类别/治疗区域在报告上将药物分组在一起，从而允许医师容易且快速地从对该患者最适合的特定药物类别中识别药物根据他们的整个药物遗传学测试结果。该方法的输出可作为医生的快速指南添加到现有的药物遗传学检测报告中。这种将来自多个基因的药物遗传学信息和产品以药物为中心的组织结合起来应该能够让医生更容易地将药物遗传学检测应用到他们的实践中。

IPRDB

热门服务

关于我们

友情链接

联系方式